$1.34 per share by the sounds of it.
great breakdown and whilst there are some variables in OpEx such as people costs, the mapping of revenue growth looks good and we are looking at a near 4X from current prices
- Forums
- ASX - By Stock
- Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023
$1.34 per share by the sounds of it. great breakdown and whilst...
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
-0.015(10.0%) |
Mkt cap ! $39.44M |
Open | High | Low | Value | Volume |
15.5¢ | 15.5¢ | 13.5¢ | $119.9K | 836.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28579 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 24827 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28579 | 0.135 |
5 | 45902 | 0.130 |
2 | 26000 | 0.125 |
6 | 174170 | 0.120 |
4 | 55960 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 24827 | 1 |
0.155 | 55949 | 3 |
0.160 | 54816 | 2 |
0.165 | 1500 | 1 |
0.170 | 36539 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online